(Q40108444)

English

Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells (English)

1 reference

Europe PubMed Central

17 September 2017

phosphatidylcholines

1 reference

based on heuristic

inferred from title

pulmonary surfactant

1 reference

based on heuristic

inferred from title

author name string

Naoki Ishiguro

1

1 reference

Europe PubMed Central

17 September 2017

Masanobu Oyabu

2

1 reference

Europe PubMed Central

17 September 2017

Toshihiro Sato

3

1 reference

Europe PubMed Central

17 September 2017

Tomoji Maeda

4

1 reference

Europe PubMed Central

17 September 2017

Hironobu Minami

5

1 reference

Europe PubMed Central

17 September 2017

Ikumi Tamai

6

1 reference

Europe PubMed Central

17 September 2017

publication date

12 July 2007

1 reference

Europe PubMed Central

17 September 2017

Pharmaceutical Research

1 reference

Europe PubMed Central

17 September 2017

25

1 reference

Europe PubMed Central

17 September 2017

2

1 reference

Europe PubMed Central

17 September 2017

417-427

1 reference

Europe PubMed Central

17 September 2017

Diffuse alveolar damage after ZD1839 therapy in a patient with non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9362-9

21 January 2018

Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9362-9

21 January 2018

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9362-9

21 January 2018

Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9362-9

21 January 2018

Allometric relationships of cell numbers and size in the mammalian lung

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9362-9

21 January 2018

Selection and characterization of the choline transport mutation suppressor from Torpedo electric lobe, CTL1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloning and characterization of two human polyspecific organic cation transporters

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 1999.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of the high-affinity choline transporter in the central nervous system of the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular cloning of a human, hemicholinium-3-sensitive choline transporter

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ABCA3 deficiency: neonatal respiratory failure and interstitial lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An electric lobe suppressor for a yeast choline transport mutation belongs to a new family of transporter-like proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The type II epithelial cell of the lung. I. Method of isolation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Organic cation transporter mRNA and function in the rat superior cervical ganglion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surfactant and acute lung injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe acute interstitial pneumonia and gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ABCA3 as a Lipid Transporter in Pulmonary Surfactant Biogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and characterization of the high-affinity choline transporter

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired trafficking of choline transporter-like protein-1 at plasma membrane and inhibition of choline transport in THP-1 monocyte-derived macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An improved method for isolating type II cells in high yield and purity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sudden onset of interstitial lung disease induced by gefitinib in a lung cancer patient with multiple drug allergy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sodium-dependent and -independent choline uptake by type II epithelial cells from rat lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The transport of choline

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17624579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11095-007-9362-9

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40108444&oldid=1885597405"